Molecular biology studies in Philadelphia chromosome-negative chronic myeloid leukemia. 1988

A Tassinari, and A Zaccaria, and G Saglio, and A Guerrasio, and N Testoni, and B Celso, and G Rosti, and G R Cambrin, and S Tura

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010677 Philadelphia Chromosome An aberrant form of human CHROMOSOME 22 characterized by translocation of the distal end of chromosome 9 from 9q34, to the long arm of chromosome 22 at 22q11. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia (LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE). Ph1 Chromosome,Ph 1 Chromosome,1 Chromosomes, Ph,Chromosome, Ph 1,Chromosome, Ph1,Chromosome, Philadelphia,Chromosomes, Ph 1,Chromosomes, Ph1,Ph 1 Chromosomes,Ph1 Chromosomes
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015321 Gene Rearrangement The ordered rearrangement of gene regions by DNA recombination such as that which occurs normally during development. DNA Rearrangement,DNA Rearrangements,Gene Rearrangements,Rearrangement, DNA,Rearrangement, Gene,Rearrangements, DNA,Rearrangements, Gene
D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. Granulocytic Leukemia, Chronic,Leukemia, Granulocytic, Chronic,Leukemia, Myelocytic, Chronic,Leukemia, Myelogenous, Chronic,Leukemia, Myeloid, Chronic,Myelocytic Leukemia, Chronic,Myelogenous Leukemia, Chronic,Myeloid Leukemia, Chronic,Leukemia, Chronic Myelogenous,Leukemia, Chronic Myeloid,Leukemia, Myelogenous, Ph1 Positive,Leukemia, Myelogenous, Ph1-Positive,Leukemia, Myeloid, Ph1 Positive,Leukemia, Myeloid, Ph1-Positive,Leukemia, Myeloid, Philadelphia Positive,Leukemia, Myeloid, Philadelphia-Positive,Myelogenous Leukemia, Ph1-Positive,Myeloid Leukemia, Ph1-Positive,Myeloid Leukemia, Philadelphia-Positive,Chronic Granulocytic Leukemia,Chronic Granulocytic Leukemias,Chronic Myelocytic Leukemia,Chronic Myelocytic Leukemias,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemias,Chronic Myeloid Leukemia,Chronic Myeloid Leukemias,Granulocytic Leukemias, Chronic,Leukemia, Chronic Granulocytic,Leukemia, Chronic Myelocytic,Leukemia, Ph1-Positive Myelogenous,Leukemia, Ph1-Positive Myeloid,Leukemia, Philadelphia-Positive Myeloid,Leukemias, Chronic Granulocytic,Leukemias, Chronic Myelocytic,Leukemias, Chronic Myelogenous,Leukemias, Chronic Myeloid,Leukemias, Ph1-Positive Myelogenous,Leukemias, Ph1-Positive Myeloid,Leukemias, Philadelphia-Positive Myeloid,Myelocytic Leukemias, Chronic,Myelogenous Leukemia, Ph1 Positive,Myelogenous Leukemias, Chronic,Myelogenous Leukemias, Ph1-Positive,Myeloid Leukemia, Ph1 Positive,Myeloid Leukemia, Philadelphia Positive,Myeloid Leukemias, Chronic,Myeloid Leukemias, Ph1-Positive,Myeloid Leukemias, Philadelphia-Positive,Ph1-Positive Myelogenous Leukemia,Ph1-Positive Myelogenous Leukemias,Ph1-Positive Myeloid Leukemia,Ph1-Positive Myeloid Leukemias,Philadelphia-Positive Myeloid Leukemia,Philadelphia-Positive Myeloid Leukemias

Related Publications

A Tassinari, and A Zaccaria, and G Saglio, and A Guerrasio, and N Testoni, and B Celso, and G Rosti, and G R Cambrin, and S Tura
January 1973, Haematologia,
A Tassinari, and A Zaccaria, and G Saglio, and A Guerrasio, and N Testoni, and B Celso, and G Rosti, and G R Cambrin, and S Tura
October 2019, American journal of hematology,
A Tassinari, and A Zaccaria, and G Saglio, and A Guerrasio, and N Testoni, and B Celso, and G Rosti, and G R Cambrin, and S Tura
January 1993, Acta haematologica Polonica,
A Tassinari, and A Zaccaria, and G Saglio, and A Guerrasio, and N Testoni, and B Celso, and G Rosti, and G R Cambrin, and S Tura
January 1974, Hereditas,
A Tassinari, and A Zaccaria, and G Saglio, and A Guerrasio, and N Testoni, and B Celso, and G Rosti, and G R Cambrin, and S Tura
September 1992, Medicina clinica,
A Tassinari, and A Zaccaria, and G Saglio, and A Guerrasio, and N Testoni, and B Celso, and G Rosti, and G R Cambrin, and S Tura
February 1989, Cancer genetics and cytogenetics,
A Tassinari, and A Zaccaria, and G Saglio, and A Guerrasio, and N Testoni, and B Celso, and G Rosti, and G R Cambrin, and S Tura
May 1994, Orvosi hetilap,
A Tassinari, and A Zaccaria, and G Saglio, and A Guerrasio, and N Testoni, and B Celso, and G Rosti, and G R Cambrin, and S Tura
October 1993, Medicina clinica,
A Tassinari, and A Zaccaria, and G Saglio, and A Guerrasio, and N Testoni, and B Celso, and G Rosti, and G R Cambrin, and S Tura
July 2019, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
A Tassinari, and A Zaccaria, and G Saglio, and A Guerrasio, and N Testoni, and B Celso, and G Rosti, and G R Cambrin, and S Tura
August 1970, The New England journal of medicine,
Copied contents to your clipboard!